Transamerica Financial Advisors Inc. purchased a new position in shares of JD.com, Inc. (NASDAQ:JD – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,554 shares of the information services provider’s stock, valued at approximately $103,000.
Several other large investors have also recently added to or reduced their stakes in JD. Advisors Asset Management Inc. raised its holdings in JD.com by 24.0% during the first quarter. Advisors Asset Management Inc. now owns 10,433 shares of the information services provider’s stock worth $286,000 after purchasing an additional 2,022 shares in the last quarter. Tidal Investments LLC purchased a new position in JD.com in the first quarter valued at about $849,000. Cetera Advisors LLC purchased a new position in JD.com in the first quarter valued at about $280,000. Teachers Retirement System of The State of Kentucky increased its holdings in JD.com by 20.9% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 369,100 shares of the information services provider’s stock valued at $10,110,000 after buying an additional 63,800 shares in the last quarter. Finally, SRN Advisors LLC increased its holdings in JD.com by 89.3% in the first quarter. SRN Advisors LLC now owns 56,644 shares of the information services provider’s stock valued at $1,551,000 after buying an additional 26,726 shares in the last quarter. 15.98% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
JD has been the subject of a number of research analyst reports. Loop Capital raised shares of JD.com from a “hold” rating to a “buy” rating and dropped their target price for the company from $49.00 to $48.00 in a report on Monday, October 21st. Sanford C. Bernstein dropped their target price on shares of JD.com from $35.00 to $32.00 and set a “market perform” rating for the company in a report on Friday, August 16th. Benchmark reaffirmed a “buy” rating and issued a $47.00 target price on shares of JD.com in a report on Friday, November 15th. Barclays increased their price target on shares of JD.com from $40.00 to $50.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Finally, Susquehanna reiterated a “neutral” rating and issued a $28.00 price target on shares of JD.com in a research report on Monday, August 19th. Three equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, JD.com has an average rating of “Moderate Buy” and a consensus price target of $40.36.
JD.com Stock Up 5.3 %
Shares of NASDAQ JD opened at $37.19 on Thursday. JD.com, Inc. has a 1 year low of $20.82 and a 1 year high of $47.82. The firm’s 50 day moving average price is $38.77 and its 200 day moving average price is $31.73. The firm has a market cap of $58.65 billion, a P/E ratio of 11.77, a price-to-earnings-growth ratio of 0.28 and a beta of 0.41. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.90 and a current ratio of 1.17.
JD.com Company Profile
JD.com, Inc operates as a supply chain-based technology and service provider in the People's Republic of China. The company offers computers, communication, and consumer electronics products, as well as home appliances; and general merchandise products comprising food, beverage and fresh produce, baby and maternity products, furniture and household goods, cosmetics and other personal care items, pharmaceutical and healthcare products, industrial products, books, automobile accessories, apparel and footwear, bags, and jewelry.
Further Reading
- Five stocks we like better than JD.com
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 Fintech Stocks With Good 2021 Prospects
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Manufacturing Stocks Investing
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for JD.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JD.com and related companies with MarketBeat.com's FREE daily email newsletter.